Prospective, randomized, open-label trial evaluating the safety, tolerability and efficacy of ertapenem versus triple antibiotic therapy in treatment of children with perforated appendicitis

Trial Profile

Prospective, randomized, open-label trial evaluating the safety, tolerability and efficacy of ertapenem versus triple antibiotic therapy in treatment of children with perforated appendicitis

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2015

At a glance

  • Drugs Ertapenem (Primary) ; Ampicillin; Gentamicin; Metronidazole
  • Indications Appendicitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top